IQVIA Holdings Inc. filed a Form 8-K with the SEC on September 23, 2026, disclosing that its wholly owned subsidiary, IQVIA Inc., completed the issuance and sale of $2,000,000,000 in gross proceeds of 6.375% senior notes due 2034 on that same date.
Stoneridge, Inc. (NYSE:SRI) filed a Form 8-K on September 23, 2026, disclosing that it entered into an employment agreement with Uwe Brandenburg, who will serve as Global Vice President, Engineering & Innovation effective November 2, 2026.
KLX Energy Services Holdings, Inc. filed a current report on September 23, 2026, disclosing that its Board of Directors adopted a stockholder protection rights plan and declared a dividend of one right per outstanding share of common stock.
Bio-Techne Corporation filed a Form 8-K on September 23, 2026, reporting the results of a special shareholder meeting held that same day to vote on a proposed merger with Merck KGaA, Darmstadt, Germany.
Sunrise Realty Trust, Inc. filed a current report on Form 8-K on September 23, 2026, disclosing that its Board of Directors approved the appointment of Howard Sudnow as an independent director, effective upon completion of the company's planned merger with Southern Realty Trust Inc.
Greenland Mines Ltd. filed a Form 8-K on September 23, 2026, disclosing the entry into a securities purchase agreement with institutional investors for a direct registered offering of common stock and pre-funded warrants expected to raise approximately $38.4 million in net proceeds.
IB Acquisition Corp. filed a Form 8-K/A on September 23, 2026, amending its earlier Current Report dated September 19, 2026, to add a description of the Commitment Note issued under the Equity Purchase Facility Agreement and to include a subheading for Item 3.02 relating …
Centerspace filed an 8-K with the SEC on September 23, 2026, disclosing that on September 22, 2026, it entered into an Amendment to the Agreement and Plan of Merger with Independence Realty Trust, Inc. and related parties, implementing a modified merger structure.
Xenetic Biosciences, Inc. filed a current report on Form 8-K with the SEC on September 23, 2026, disclosing the release of an updated investor presentation related to its pending share exchange transaction with Santersus AG.
NexGel, Inc. filed a Form 8-K on September 23, 2026, reporting the results of its 2026 Special Meeting of Stockholders, at which shareholders approved three proposals relating to amendments to the company's Certificate of Incorporation.